STAAR to buy out Canon Staar

Article

STAAR Surgical has entered into an agreement to acquire the interests of all other shareholders in Canon Staar.

STAAR Surgical has entered into an agreement to acquire the interests of all other shareholders in Canon Staar, a joint venture that was formed by STAAR, Canon and Canon Marketing Japan.

Canon Staar was created to develop, manufacture and sell in Japan, products using STAAR's technology. At closing, STAAR will pay to the Canon companies $4 million in cash and $1.7 million newly issued shares of Series A Convertible Preferred Stock. This stock will be convertible into common stock at a one-to-one ratio and, under certain circumstances, will be redeemable for cash at $4 per share.

Canon Staar currently manufactures and sells the Preloaded Injector, a silicone or acrylic intraocular lens packaged and shipped in a pre-sterilized, disposable injector ready for use in cataract surgery.

On closing, the company will be renamed STAAR Japan and will become a wholly-owned subsidiary of STAAR.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.